Volume 10, Number 5—May 2004
Dispatch
Hemolytic Uremic Syndrome Incidence in New York1
Table 2
Characteristics | Escherichia coli O157:H7 culture |
||
---|---|---|---|
Positive (n = 34) | Negative (n = 20) | p value | |
Mean age at admission (y) | 23.6 | 23.7 | 0.99 |
Mean length of hospital stay (days) | 13.4 | 12.6 | 0.71 |
Mean duration from diarrhea onset to specimen collection date (days) | 4.1 | 6.0 | 0.06 |
Median duration from admission date to specimen collection date (days) | 0 | 1.0 | 0.02 |
Mean BUN (mg/dL) | 62.1 | 82.6 | 0.05 |
Mean creatinine (mg/dL) | 3.6 | 4.8 | 0.24 |
Mean platelet count (/103) | 50.9 | 53.8 | 0.81 |
Mean leukocyte count (/103) | 18.5 | 21.4 | 0.23 |
% outbreak related | 38% | 5% | 0.01 |
% blood in stool | 82% | 65% | 0.15 |
% reported to surveillance | 88% | 55% | 0.01 |
% microangiopathic change | 79% | 100% | 0.03 |
% urinary tract infection | 3% | 20% | 0.04 |
aHUS, hemolytic uremic syndrome; E. coli, Escherichia coli; BUN, blood urea nitrogen.
1This paper was presented at the International Conference on Emerging Infectious Diseases, held March 24–27, 2002, in Atlanta, Georgia, USA.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.